Patents by Inventor Cécile Servais

Cécile Servais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical semi-solid composition of isotretinoin
    Patent number: 9089534
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: July 28, 2015
    Assignee: Galephar Pharmaceutical Research, Inc.
    Inventors: Francis Vanderbist, Cecile Servais, Philippe Baudier
  • Pharmaceutical semi-solid composition of isotretinoin
    Patent number: 9078925
    Abstract: The invention relates to an oral pharmaceutical composition of isotretinoin at least two excipients, one of the excipients being a hydrophilic excipient having an HLB value greater than or equal to 10 and the other excipient being an oily vehicle. The oral pharmaceutical composition is substantially devoid of food effect as characterized by a dissolution profile wherein at least 70% of the oral pharmaceutical composition is dissolved after about four hours in a USP2 dissolution apparatus at a paddle speed of 100 rpm, and a dissolution media composed of 900 mL of pH 7.5 buffer containing 0.11% pancreatin, 4.7% cholic acid, 0.14% sodium dihydroxide phosphate and 0.5% sodium hydroxide at 37° C.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: July 14, 2015
    Assignee: GALEPHAR PHARMACEUTICAL RESEARCH, INC.
    Inventors: Arthur M. DeBoeck, Francis Vanderbist, Cecile Servais, Philippe Baudier
  • Pharmaceutical semi-solid composition of isotretinoin
    Patent number: 8952064
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: February 10, 2015
    Assignee: Galephar Pharmaceutical Research, Inc.
    Inventors: Francis Vanderbist, Cécile Servais, Philippe Baudier
  • PHARMACEUTICAL SEMI-SOLID COMPOSITION OF ISOTRETINOIN
    Publication number: 20140107203
    Abstract: The invention relates to an oral pharmaceutical composition of isotretinoin at least two excipients, one of the excipients being a hydrophilic excipient having an HLB value greater than or equal to 10 and the other excipient being an oily vehicle. The oral pharmaceutical composition is substantially devoid of food effect as characterized by a dissolution profile wherein at least 70% of the oral pharmaceutical composition is dissolved after about four hours in a USP2 dissolution apparatus at a paddle speed of 100 rpm, and a dissolution media composed of 900 mL of pH 7.5 buffer containing 0.11% pancreatin, 4.7% cholic acid, 0.14% sodium dihydroxide phosphate and 0.5% sodium hydroxide at 37° C.
    Type: Application
    Filed: December 18, 2013
    Publication date: April 17, 2014
    Applicant: GALEPHAR PHARMACEUTICAL RESEARCH, INC.
    Inventors: Arthur M. DEBOECK, Francis VANDERBIST, Cecile SERVAIS, Philippe BAUDIER
  • PHARMACEUTICAL SEMI-SOLID COMPOSITION OF ISOTRETINOIN
    Publication number: 20130217769
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: December 13, 2012
    Publication date: August 22, 2013
    Applicants: GALEPHAR M/F
    Inventors: Francis Vanderbist, Cécile Servais, Phillippe Baudier
  • PHARMACEUTICAL SEMI-SOLID COMPOSITION OF ISOTRETINOIN
    Publication number: 20130158119
    Abstract: Pharmaceutical semi-solid composition of Isotretinoin An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: June 18, 2012
    Publication date: June 20, 2013
    Inventors: Francis Vanderbist, Cécile Servais, Philippe Baudier
  • PHARMACEUTICAL SEMI-SOLID COMPOSITION OF ISOTRETINOIN
    Publication number: 20130096196
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: June 18, 2012
    Publication date: April 18, 2013
    Inventors: Franois Vanderbist, Cécile Servais, Philippe Baudier
  • Pharmaceutical semi-solid composition of isotretinoin
    Patent number: 8367102
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: February 5, 2013
    Assignee: Galephar Pharmaceutical Research, Inc.
    Inventors: Francis Vanderbist, Cécile Servais, Phillippe Baudier
  • Pharmaceutical semi-solid composition of isotretinoin
    Patent number: 7435427
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: October 14, 2008
    Assignee: Galephar M/F
    Inventors: Francis Vanderbist, Cecile Servais, Philippe Baudier
  • Pharmaceutical semi-sold composition of isotretinoin
    Publication number: 20080171084
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: August 22, 2007
    Publication date: July 17, 2008
    Applicant: GALEPHAR M/F
    Inventors: Francis VANDERBIST, Cecile SERVAIS, Phillippe BAUDIER
  • Pharmaceutical semi-solid composition of isotretinoin
    Publication number: 20040009225
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: July 30, 2003
    Publication date: January 15, 2004
    Inventors: Francis Vanderbist, Cecile Servais, Philippe Baudier